根据提交给美国证券交易委员会(SEC)的文件,生物制药公司 Minerva Neurosciences 计划通过投资银行 Leerink Partners 进行普通股的公开发行,筹资总额最高可达7500万美元。
根据提交给美国证券交易委员会(SEC)的文件,生物制药公司 Minerva Neurosciences 计划通过投资银行 Leerink Partners 进行普通股的公开发行,筹资总额最高可达7500万美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.